On August 5, 2024, the Company received a letter from the NASDAQ Hearings Panel that, following the Company’s hearing before the Panel on July 23, 2024, NASDAQ has determined to delist the Company’s common stock and that trading in the Company’s securities will be suspended from NASDAQ at the open of trading on August 7, 2024. It is anticipated that the Company’s common stock will be subject to quotation and trading on the over-the-counter market as of August 7, 2024 under the Company’s existing trading symbol “SPEC.”
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SPEC:
- Spectaire Holdings announces initial delivery of 500 AireCore unit order
- Spectaire Announces Initial Delivery of a 500 AireCore Unit Order with $5 Million Annual Recurring Revenue Potential
- Spectaire Holdings Enhances Board with UPS Veteran
- Spectaire Holdings announces upcoming release of AireCore 2.0
- Spectaire Unveils AireCore 2.0: Opening New Revenue Opportunities in Pharmaceuticals, Environmental Analysis, and Advanced Materials Research